StocktoriaPRF Technologies Ltd. PRFX
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
3/9
Piotroski F — financial health
-15.16
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $17,000 | $0 | $0 | — | — |
| Operating income | -$5.1M | -$14.7M | -$9.6M | -$8.9M | -$7.2M |
| Net income | -$5.0M | -$14.6M | -$9.3M | -$8.8M | -$7.2M |
| Operating cash flow | -$4.0M | -$12.6M | -$6.7M | -$6.5M | -$6.6M |
| Free cash flow | -$4.0M | -$12.6M | -$6.7M | -$6.5M | -$6.6M |
| Total assets | $12.0M | $4.5M | $9.9M | $12.3M | $19.1M |
| Total liabilities | $2.7M | $2.7M | $2.7M | $1.3M | $991,000 |
| Shareholders' equity | $8.5M | $1.8M | $7.2M | $11.0M | $18.1M |
| Ratios | |||||
| Operating margin | -30129.4% | — | — | — | — |
| Net margin | -29541.2% | — | — | — | — |
| FCF margin | -23276.5% | — | — | — | — |
| Return on assets | -41.9% | -322.4% | -94.1% | -71.3% | -38.0% |
| Return on equity | -58.8% | -799.8% | -129.1% | -79.8% | -40.1% |
| Current ratio | 1.78 | 1.81 | 4.07 | 11.55 | 25.13 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -15.16 (distress)
- Working capital / assets 0.159
- Retained earnings / assets -5.108
- EBIT / assets -0.427
- Equity / liabilities 3.155
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001801834 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.